Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240001/S003

PearlMatrixTM Peptide Enhanced Bone Graft

Cerapedics, Inc. · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONP240001/S003

What did the FDA decide?

Cerapedics, Inc. holds PMA P240001 for a synthetic peptide bone void filler (product code NOX, orthopedic). Supplement S003, a 30-Day Notice categorized as a process change involving a manufacturer, sterilizer, packager, or supplier, was filed to cover changes in P-15 manufacturing at Bachem Americas. The stated purpose is "equipment technological advancements and to improve process efficiency," alongside a series of minor or administrative specification changes. Because the record identifies this as a supplement to P240001, it is a modification notice tied to the existing approval, not an original PMA and not a new approval of the whole device system.

The supplied statement is broad. It does not name specific equipment, quantify the efficiency change, list which specifications moved, or report data on product performance. The reported purpose describes the manufacturer's rationale; it is not independent evidence of safety or clinical effectiveness, and no clinical use or new indication can be drawn from it.

FDA approval order statement

changes to the P-15 manufacturing occurring at Bachem Americas due to equipment technological advancements and to improve process efficiency , as well as a series of minor/administrative specifications changes
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Sep 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240001/S003
Regulatory pathway
PMA supplement
Product code
NOX
Decision code
OK30
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, bone void, synthetic peptide.

Product code
NOX
FDA device class
3

For the original device and its historical approval scope, see PMA P240001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240001 · Original PMA

    PearlMatrix Bone Graft

  2. P240001/S003 received

    Application receipt date recorded by FDA.

  3. P240001/S003 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P240001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240001

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, Inc.PMA approvalJun 18, 2025FDA

Explore the linked device profile

Other records with product code NOX

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, LLCPMA supplementSep 16, 2026FDA
Cerapedics, LLCPMA approvalNov 3, 2015FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cerapedics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11025 Dover St., Suite 1600, Westminster, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records